(IN BRIEF) Roche has completed the acquisition of LumiraDx’s Point of Care technology after receiving all necessary antitrust and regulatory clearances. This addition enhances Roche’s diagnostics portfolio with an advanced multi-assay platform that consolidates a wide range of tests, including … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged acquisition, Global Diagnostic Capabilities, LumiraDx’s Point of Care Technology, Matt Sause, partnership, Roche, sustainability, Veronique Ameye
(IN BRIEF) Merck has signed an MoU with Gene Therapy Research Institution Co., Ltd. (GTRI) to support the production of gene therapy for Parkinson’s Disease using Merck’s Sf-RVN® Insect Cell Line platform. This collaboration aims to enhance the manufacturing process … Read the full press release
Posted in Business, Education, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Gene Therapy Production, Gene Therapy Research Institution Co. Ltd. (GTRI), Isao Hatano, Japan, Merck, Parkinson's disease, partnership, sustainability
(IN BRIEF) Just – Evotec Biologics and Sandoz have expanded their strategic partnership to advance the development and commercial manufacturing of biosimilars. This enhanced collaboration includes additional biosimilars in Sandoz’s pipeline and ensures long-term supply through Just – Evotec Biologics’ … Read the full press release
Posted in Business, Environment, Financial, France, Germany, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged Biosimilar Development, Dr. Matthias Evers, Evotec, France, Just – Evotec Biologics, partnership, Sandoz, Supply Security, sustainability, Switzerland
(IN BRIEF) The European Investment Bank (EIB) has awarded Belgium-based medtech company Nyxoah €37.5 million in venture-debt financing to support the development of innovative treatments for obstructive sleep apnea (OSA). This funding, backed by the InvestEU Life Sciences programme, will … Read the full press release
Posted in Banks, Belgium, European Union, Financial, Healthcare, Pharma & Biotech
Tagged Belgium, commercialization, EIB, equity offering, Europe, European Investment Bank, financing, Genio system, hypoglossal neurostimulation therapy, INNOVATION, InvestEU, InvestEU Life Sciences programme, life sciences, manufacturing capacity, medtech, Nyxoah, obstructive sleep apnea, Olivier Taelman, OSA, production capacity, research and development, Robert de Groot, technological innovation, US, venture-debt financing
(IN BRIEF) SGS has expanded its laboratory in Birsfelden, Switzerland, to offer comprehensive stability studies as part of its biopharmaceutical service portfolio. Effective February 2024, the enhanced facility provides integrated services including controlled temperature storage and various analytical tests, ensuring … Read the full press release
(IN BRIEF) Roche has introduced the VENTANA® Kappa and Lambda Dual ISH mRNA Probe Cocktail assay, the first clinically approved in-situ hybridisation (ISH) test of its kind. Designed to enhance sensitivity in diagnosing B-cell lymphoma, the assay helps differentiate cancerous … Read the full press release
(IN BRIEF) Merck and The Michael J. Fox Foundation (MJFF) are collaborating to advance Parkinson’s disease research using Merck’s SMCxPRO® immunoassay technology. This initiative aims to detect biomarkers indicating cell dysfunction in PD patients, enhancing research into new treatment options … Read the full press release
Posted in Business, Education, Environment, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Innovative Biomarker Technology, Jean-Charles Wirth, Merck, Michael J. Fox Foundation, Nicole Polinski, Parkinson's Research, partnership, SMCxPRO® immunoassay technology, sustainability
(IN BRIEF) QIAGEN has launched an upgraded version of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret), tailored for high-throughput next-generation sequencing (NGS) labs. The new release enhances performance metrics like turnaround time and diagnostic yield through … Read the full press release
(IN BRIEF) Merck is investing €62 million in a new quality control facility at its Darmstadt headquarters as part of a larger €1.5 billion investment program. Scheduled for completion by mid-2025, the state-of-the-art facility will consolidate 135 employees into a … Read the full press release
Posted in Business, Environment, Financial, Germany, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Darmstadt, expansion, facility, Life Science, Merck, partnership, Quality Standards, Robert Nass, sustainability
(IN BRIEF) Swissport’s air cargo center at Frankfurt Airport has once again earned CEIV Pharma certification from IATA, highlighting its commitment to excellence in handling pharmaceutical products. This certification reaffirms Swissport’s dedication to maintaining high-quality standards in pharmaceutical logistics, supporting … Read the full press release
Posted in Aviation & Aerospace, Business, Environment, Financial, Germany, Government, Industrial, Investment, Management, News, Pharma & Biotech, Security & Safety, Switzerland, Transportation & Logistics
Tagged Andreas Behnke, CEIV Pharma Certification, Dirk Goovaerts, Frankfurt Air Cargo Center, Frankfurt Airport, IATA, Pharmaceutical, Quality Handling, safety, Swissport
(IN BRIEF) In a significant stride towards combating metabolic dysfunction-associated steatohepatitis (MASH), Boehringer Ingelheim unveils groundbreaking results from a Phase II trial sub-analysis of survodutide. Demonstrating impressive efficacy, up to 64.5% of adults with moderate to advanced fibrosis stages F2 … Read the full press release
(IN BRIEF) Merck, a leading science and technology company, has inaugurated its expanded Life Science distribution center in Schnelldorf, Germany, following a €180 million investment that nearly doubled its size to 25,000 square meters. The upgraded facility now includes manual … Read the full press release
(IN BRIEF) Novartis has presented new data at the 2024 European Academy of Allergy and Clinical Immunology (EAACI) Congress, showcasing the sustained efficacy and safety of remibrutinib, a selective Bruton’s tyrosine kinase (BTK) inhibitor, in chronic spontaneous urticaria (CSU). Results … Read the full press release
(IN BRIEF) Evotec SE announces a partnership with Inserm, Lille University Hospital, and Inserm Transfert to identify novel therapeutic targets and diagnostic markers in obesity and metabolic diseases. The collaboration, centered around the ABOS/DIABOMICS study led by Lille University Hospital, … Read the full press release
Posted in Business, Education, Financial, France, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Dr Cord Dohrmann, Evotec, France, Inserm, Lille University Hospital, metabolic disease, Noémie Pellegrin, Obesity, partnership, Prof. Bart Staels, Prof. Francois Pattou, RESEARCH, sustainability
(IN BRIEF) Almirall’s new data highlights the alarming lack of awareness regarding actinic keratosis (AK), a common precancerous dermatological condition linked to sun exposure, with more than one-third of affected individuals unaware of its causes. The survey, conducted across Spain, … Read the full press release
(IN BRIEF) A recent study commissioned by Boehringer Ingelheim, conducted across eight G20 countries, sheds light on the challenges obstructing access to mental health care worldwide. The analysis reveals pervasive stigma, a shortage of mental health professionals, and inconsistent service … Read the full press release
(IN BRIEF) Roche (SIX: RO, ROG; OTCQX: RHHBY) reveals the retirement of James Sabry, the Head of Roche Pharma Partnering, after fourteen years of service. Effective 1 July 2024, Boris Zaïtra, currently Head of Group Business Development, will take on … Read the full press release
Posted in Business, Industrial, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged appointment, Boris Zaïtra, James Sabry, leadership, retirement, Roche, Thomas Schinecker
(IN BRIEF) The European Parliament has achieved a significant milestone by approving the first reading of extensive reforms to EU pharmaceutical legislation aimed at fostering innovation and ensuring equitable access to medicines. While commending the progress, the European Society of … Read the full press release
Posted in Business, France, Healthcare, Industrial, Law, Management, News, Pharma & Biotech, Science, Technology
Tagged ESC, European Parliament, Pharmaceutical Legislation Reform, Professor Piotr Szymański
(IN BRIEF) Boehringer Ingelheim and OSE Immunotherapeutics announce a significant expansion of their partnership, introducing two novel projects to develop pioneering treatments alongside their ongoing anti-SIRPα immuno-oncology initiatives. The expansion includes broadening therapeutic evaluations to encompass cardiovascular-renal-metabolic (CRM) diseases and … Read the full press release
Posted in Business, Education, Environment, Financial, France, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Boehringer Ingelheim, Clive R. Wood, Disease Treatment, Nicolas Poirier, OSE Immunotherapeutics, partnership, sustainability
(IN BRIEF) Roche Diagnostics has announced that its Tina-quant® lipoprotein Lp(a) RxDx assay has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). Developed in collaboration with Amgen, this innovative test aims to identify individuals at risk … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Amgen, Cardiovascular Disease Risk, Jay Bradner, Lp(a) Test, Matt Sause, partnership, Roche, safety, sustainability
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?